Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds. The reason for such a low rate, researchers suggest, may be a lack of time for providing the counseling or expertise in this area by clinicians.
Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Prediabetes increases the risk of dying before age 75, particularly due to heart disease, kidney disease and acute diabetic complications, according to a new study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
The cardiovascular ICU at the University of Mississippi Medical Center developed a simulation training program to improve clinicians’ ability to recognize clinical signs that would prompt an emergency ICU sternotomy for a postoperative cardiac surgery patient and rehearse the high-risk but infrequent procedure.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
A new mouse study of heart failure with preserved ejection fraction (HFpEF) found sex differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to combating cardiovascular disease worldwide
The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.
Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the UC San Diego have developed new, efficient genome editing tools called multiplexed orthogonal base editors (MOBEs) to install multiple point mutations at once.
Rutgers Health researchers tie infertility treatment to a particular risk for hypertensive diseases.
Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.
A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.
Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.
The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.
One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right